| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
674,040,000 |
| Market
Cap: |
14.92(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$17.15 - $26.07 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Avantor is a global manufacturer and distributor that provides products and services to customers in the biopharmaceutical, healthcare, education and government and advanced technologies and applied materials industries. Co.'s portfolio includes: Materials and consumables, such as lab products and supplies, formulated silicone materials, customized excipients, and customized single-use assemblies; equipment and instrumentation, such as filtration systems, virus inactivation systems, and incubators; and services and specialty procurement, such as onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
27,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$573,100 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
27,872 |
60,449 |
104,821 |
| Total Sell Value |
$0 |
$687,456 |
$1,380,595 |
$2,464,073 |
| Total People Sold |
0 |
3 |
4 |
5 |
| Total Sell Transactions |
0 |
4 |
6 |
13 |
| End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Vanderhaegen Frederic |
EVP, Europe |
• – – |
2021-04-12 |
4 |
AS |
$31.75 |
$860,997 |
D/D |
(27,075) |
216,594 |
|
18% |
|
| Miller Justin |
EVP & General Counsel |
• – – |
2021-04-12 |
4 |
AS |
$31.75 |
$3,412,916 |
D/D |
(102,895) |
118,679 |
|
18% |
|
| Miller Justin |
EVP & General Counsel |
• – – |
2021-04-12 |
4 |
OE |
$23.21 |
$2,321,000 |
D/D |
100,000 |
218,679 |
|
- |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2021-04-12 |
4 |
AS |
$32.37 |
$3,242,179 |
D/D |
(100,160) |
155,888 |
|
18% |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2021-04-12 |
4 |
OE |
$1.60 |
$160,256 |
D/D |
100,160 |
256,048 |
|
- |
|
| Couturier Christophe |
EVP, AMEA |
• – – |
2021-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,267 |
177,459 |
|
- |
|
| Vanderhaegen Frederic |
EVP, Europe |
• – – |
2021-03-09 |
4 |
S |
$28.21 |
$282,100 |
D/D |
(10,000) |
243,669 |
|
-29% |
|
| Wondrasch Michael |
EVP & CIO |
• – – |
2021-03-02 |
4 |
S |
$28.71 |
$87,164 |
D/D |
(3,036) |
145,438 |
|
-26% |
|
| Severino Michael |
Director |
– • – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
7,236 |
17,258 |
|
- |
|
| Stubblefield Michael |
President and CEO |
• • – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
72,359 |
1,509,481 |
|
- |
|
| Lewis Sheri |
EVP, Global Ops & Supply Chain |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
13,567 |
66,856 |
|
- |
|
| Henson Meghan |
EVP, Chief HR Officer |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,140 |
25,902 |
|
- |
|
| Couturier Christophe |
EVP, Services |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,784 |
169,192 |
|
- |
|
| Sachdev Rakesh |
Director |
– • – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
7,236 |
32,841 |
|
- |
|
| Gupta Rajiv |
Director |
– • – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
7,236 |
1,447,952 |
|
- |
|
| Wondrasch Michael |
EVP & CIO |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,140 |
148,474 |
|
- |
|
| Szlosek Thomas A |
EVP & CFO |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
16,281 |
272,655 |
|
- |
|
| Brophy Gerard |
EVP, Biopharma Production |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
16,281 |
188,665 |
|
- |
|
| Vanderhaegen Frederic |
EVP, Europe |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
16,281 |
253,669 |
|
- |
|
| Miller Justin |
EVP & General Counsel |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,140 |
121,574 |
|
- |
|
| Andres Juan |
Director |
– • – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
7,236 |
22,187 |
|
- |
|
| Bramwell James |
EVP, Strategic Partners |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,427 |
120,641 |
|
- |
|
| Henrichwark Sven |
EVP, APAC Region |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,427 |
19,802 |
|
- |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,427 |
155,888 |
|
- |
|
| Eck Steven W |
SVP & Chief Accounting Officer |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,151 |
32,084 |
|
- |
|
534 Records found
|
|
Page 12 of 22 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.21 (0.94%) 
